Health

AstraZeneca CCP Virus Vaccine Trials Resume in UK as Regulator Gives Green Light

Save
AstraZeneca CCP Virus Vaccine Trials Resume in UK as Regulator Gives Green Light
A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken on April 10, 2020. Dado Ruvic/Illustration/File Photo/Reuters
Tom Ozimek
By Tom Ozimek, Reporter
Updated:
Clinical trials have resumed in Britain for the CCP virus vaccine being developed by AstraZeneca and Oxford University, the company said on Saturday, following a suspension earlier in the week after a study subject fell ill.

A British regulator confirmed that it is safe to proceed with the late-stage trials of the vaccine, one of the most advanced in development, AstraZeneca said in a statement.

Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics